Advanced

International comparison of trends in patients commencing renal replacement therapy by primary renal disease

Stel, Vianda S. ; Awadhpersad, Ryan ; Pippias, Maria ; Ferrer-Alamar, Manuel ; Finne, Patrik ; Fraser, Simon D. ; Heaf, James G. ; Hemmelder, Marc H. ; Martínez-Castelao, Alberto and de Meester, Johan , et al. (2019) In Nephrology 24(10). p.1064-1076
Abstract

Aim: To examine international time trends in the incidence of renal replacement therapy (RRT) for end-stage renal disease (ESRD) by primary renal disease (PRD). Methods: Renal registries reporting on patients starting RRT per million population for ESRD by PRD from 2005 to 2014, were identified by internet search and literature review. The average annual percentage change (AAPC) with a 95% confidence interval (CI) of the time trends was computed using Joinpoint regression. Results: There was a significant decrease in the incidence of RRT for ESRD due to diabetes mellitus (DM) in Europe (AAPC = −0.9; 95%CI −1.3; −0.5) and to hypertension/renal vascular disease (HT/RVD) in Australia (AAPC = −1.8; 95%CI −3.3; −0.3), Canada (AAPC = −2.9;... (More)

Aim: To examine international time trends in the incidence of renal replacement therapy (RRT) for end-stage renal disease (ESRD) by primary renal disease (PRD). Methods: Renal registries reporting on patients starting RRT per million population for ESRD by PRD from 2005 to 2014, were identified by internet search and literature review. The average annual percentage change (AAPC) with a 95% confidence interval (CI) of the time trends was computed using Joinpoint regression. Results: There was a significant decrease in the incidence of RRT for ESRD due to diabetes mellitus (DM) in Europe (AAPC = −0.9; 95%CI −1.3; −0.5) and to hypertension/renal vascular disease (HT/RVD) in Australia (AAPC = −1.8; 95%CI −3.3; −0.3), Canada (AAPC = −2.9; 95%CI −4.4; −1.5) and Europe (AAPC = −1.1; 95%CI −2.1; −0.0). A decrease or stabilization was observed for glomerulonephritis in all regions and for autosomal dominant polycystic kidney disease (ADPKD) in all regions except for Malaysia and the Republic of Korea. An increase of 5.2–16.3% was observed for DM, HT/RVD and ADPKD in Malaysia and the Republic of Korea. Conclusion: Large international differences exist in the trends in incidence of RRT by primary renal disease. Mapping of these international trends is the first step in defining the causes and successful preventative measures of CKD.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
diabetes mellitus, hypertension, primary renal disease, renal replacement therapy, trends, worldwide
in
Nephrology
volume
24
issue
10
pages
1064 - 1076
publisher
Wiley-Blackwell
external identifiers
  • scopus:85062445725
  • pmid:30456883
ISSN
1320-5358
DOI
10.1111/nep.13531
language
English
LU publication?
yes
id
6243fcce-cec1-46fc-bbcf-abded76bfceb
date added to LUP
2020-06-29 16:15:46
date last changed
2020-07-08 05:17:34
@article{6243fcce-cec1-46fc-bbcf-abded76bfceb,
  abstract     = {<p>Aim: To examine international time trends in the incidence of renal replacement therapy (RRT) for end-stage renal disease (ESRD) by primary renal disease (PRD). Methods: Renal registries reporting on patients starting RRT per million population for ESRD by PRD from 2005 to 2014, were identified by internet search and literature review. The average annual percentage change (AAPC) with a 95% confidence interval (CI) of the time trends was computed using Joinpoint regression. Results: There was a significant decrease in the incidence of RRT for ESRD due to diabetes mellitus (DM) in Europe (AAPC = −0.9; 95%CI −1.3; −0.5) and to hypertension/renal vascular disease (HT/RVD) in Australia (AAPC = −1.8; 95%CI −3.3; −0.3), Canada (AAPC = −2.9; 95%CI −4.4; −1.5) and Europe (AAPC = −1.1; 95%CI −2.1; −0.0). A decrease or stabilization was observed for glomerulonephritis in all regions and for autosomal dominant polycystic kidney disease (ADPKD) in all regions except for Malaysia and the Republic of Korea. An increase of 5.2–16.3% was observed for DM, HT/RVD and ADPKD in Malaysia and the Republic of Korea. Conclusion: Large international differences exist in the trends in incidence of RRT by primary renal disease. Mapping of these international trends is the first step in defining the causes and successful preventative measures of CKD.</p>},
  author       = {Stel, Vianda S. and Awadhpersad, Ryan and Pippias, Maria and Ferrer-Alamar, Manuel and Finne, Patrik and Fraser, Simon D. and Heaf, James G. and Hemmelder, Marc H. and Martínez-Castelao, Alberto and de Meester, Johan and Palsson, Runolfur and Prischl, Friedrich C. and Segelmark, Mårten and Traynor, Jamie P. and Santamaria, Rafael and Reisæter, Anna Varberg and Massy, Ziad A. and Jager, Kitty J.},
  issn         = {1320-5358},
  language     = {eng},
  number       = {10},
  pages        = {1064--1076},
  publisher    = {Wiley-Blackwell},
  series       = {Nephrology},
  title        = {International comparison of trends in patients commencing renal replacement therapy by primary renal disease},
  url          = {http://dx.doi.org/10.1111/nep.13531},
  doi          = {10.1111/nep.13531},
  volume       = {24},
  year         = {2019},
}